ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M601. A total of 37 filers reported holding ACORDA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
Q1 2022 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
Q4 2021 | $73,000 | -18.0% | 30,402 | +56.5% | 0.00% | – |
Q3 2021 | $89,000 | +8800.0% | 19,427 | +10875.7% | 0.00% | – |
Q2 2021 | $1,000 | -75.0% | 177 | -79.1% | 0.00% | – |
Q1 2021 | $4,000 | – | 847 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CANYON CAPITAL ADVISORS LLC | 392,904 | $1,874,000 | 0.07% |
Saltoro Capital, LP | 11,853 | $57,000 | 0.02% |
Point72 Asset Management, L.P. | 888,899 | $4,240,000 | 0.02% |
United Asset Strategies, Inc. | 27,100 | $129,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 101,590 | $485,000 | 0.01% |
ACADIAN ASSET MANAGEMENT LLC | 379,922 | $1,812,000 | 0.01% |
Virtu Financial LLC | 10,119 | $48,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 135,190 | $645,000 | 0.00% |
Renaissance Technologies | 714,118 | $3,406,000 | 0.00% |
FEDERATED HERMES, INC. | 104,816 | $500,000 | 0.00% |